Surprise finding uncovers balancing act between birth defects and cancer
(Walter and Eliza Hall Institute) Walter and Eliza Hall Institute researchers have made a surprise discovery about how subtle changes in the way cell survival is regulated during embryonic development can have drastic health implications. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 20, 2018 Category: Cancer & Oncology Source Type: news

New way to target advanced breast cancers
(Jackson Laboratory) IL1b, a member of the interleukin 1 family of cytokines (proteins released by certain cells of the immune system) drives the inflammation often found in cancer, and appears as an 'IL1 signature' in women with HER2-negative metastatic breast cancer. This signature can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 20, 2018 Category: Cancer & Oncology Source Type: news

CWRU receives NIH funding to develop new paradigm in fight against colorectal cancer
(Case Western Reserve University) Certain genes that code for proteins have long been known to contribute to cancer progression. But in a frame shift, researchers from Case Western Reserve University School of Medicine recently found that non-coding genes also contribute to the development and spreading of the disease, one of the first known examples of researchers doing so. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 20, 2018 Category: Cancer & Oncology Source Type: news

Patients with high-risk skin cancer have new treatment option
Hundreds of patients with a type of advanced skin cancer are set to benefit from a new treatment, dabrafenib plus trametinib. (Source: NHS Networks)
Source: NHS Networks - September 20, 2018 Category: UK Health Source Type: news

Predicine and Flagship Biosciences Partner to Support Global Biomarker...
Predicine and Flagship Biosciences are excited to announce a strategic venture to provide complimentary and comprehensive biomarker profiling to empower clinical trials in the immuno-oncology (IO)...(PRWeb September 20, 2018)Read the full story at https://www.prweb.com/releases/predicine_and_flagship_biosciences_partner_to_support_global_biomarker_development/prweb15773409.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 20, 2018 Category: Pharmaceuticals Source Type: news

5 Facts Every Woman Should Know About Ovarian Cancer
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - September 20, 2018 Category: Cancer & Oncology Source Type: news

No Clear Benefit for Rivaroxaban After Hospital Discharge
Incidence of major bleeding low with rivaroxaban, but clot risk not lower (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 20, 2018 Category: Cancer & Oncology Tags: Cardiology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

A superfood most people have never heard of: Jujube fruit programs cancer cells to kill themselves
(Natural News) There’s a Chinese saying that three jujubes a day keep you young forever. This might sound odd to Western audiences who tend to associate the term “jujube” with brightly colored gummy candy often found at the movie theater concession stand. However, jujube is also the name of an Asian fruit that shows tremendous... (Source: NaturalNews.com)
Source: NaturalNews.com - September 19, 2018 Category: Consumer Health News Source Type: news

Is AI the Key to Diving Deeper into Images and Pathology?
In a tale of two studies, it appears artificial intelligence is helping researchers analyze cells in ways that weren't possible before. In one study, published this week in Nature Methods, scientists at the Allen Institute in Seattle, WA used machine learning to train computers to see parts of the cell that the human eye cannot easily distinguish. Using 3D images of fluorescently labeled cells, the team taught computers to find structures inside living cells without fluorescent labels, using only black and white images generated by an inexpensive technique known as brightfield microscopy. Fluorescence microscop...
Source: MDDI - September 19, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

5 Facts Every Woman Should Know About Ovarian Cancer
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 19, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, News, Source Type: news

Medical News Today: Is carrageenan safe to eat?
Carrageenan is a controversial food additive. It is FDA-approved, but some scientists believe that it can cause inflammation, bowel disorders, and even certain cancers. In this article, we look at the research behind carrageenan, including its possible side effects, dangers, uses, and common foods that contain it. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 19, 2018 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Researchers use cancer drug and antidepressants to fight untreatable'brain-eating' infection
Cases of severe infections from the amoeba N. fowleri are rare — but there’s currently no way to stop the disease and it is almost always fatal. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 19, 2018 Category: Pharmaceuticals Source Type: news

Silicone Breast Implants Linked to Autoimmune Complications
(MedPage Today) -- FDA blasts study for " significant shortcomings " (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 19, 2018 Category: Hematology Source Type: news

FDA Grants Fast-Track Designation to CX-01 for Acute Myeloid Leukemia
CX-01, a low-anticoagulant heparin derivative, has demonstrated good rates of complete remission, rapid platelet recovery, and no serious adverse events. (Source: CancerNetwork)
Source: CancerNetwork - September 19, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Do Dose-Dense Neoadjuvant Chemo Regimens Improve Responses in Bladder Cancer?
A dose-dense neoadjuvant chemotherapy regimen yielded higher response rates compared with a standard regimen in a cohort of bladder cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - September 19, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Advances in Breast Cancer Survival Have Plateaued in the Last Decade
Survival has increased substantially for young women with breast cancer since 1975, though it has largely reached a plateau since around 2005. (Source: CancerNetwork)
Source: CancerNetwork - September 19, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

St. Louis Children ’s doctor gets $1 million grant for pediatric cancer research
The Hyundai Hope on Wheels organization awarded Dr. Todd Druley, a pediatric oncologist and hematologist at Washington University and Siteman Kids at St. Louis Children ’s Hospital, with a $1 million grant to study pediatric cancer. Children’s Hospital, part of BJC HealthCare, is one of four recipients of the Hyundai Quantum Grant this year. With this latest award, Children’s has received more than $2.6 million in grants from Hyundai Hope on Wheels, the non profit arm of Hyundai Motor America,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2018 Category: Biotechnology Authors: Veneta Rizvic Source Type: news

St. Louis Children ’s doctor gets $1 million grant for pediatric cancer research
The Hyundai Hope on Wheels organization awarded Dr. Todd Druley, a pediatric oncologist and hematologist at Washington University and Siteman Kids at St. Louis Children ’s Hospital, with a $1 million grant to study pediatric cancer. Children’s Hospital, part of BJC HealthCare, is one of four recipients of the Hyundai Quantum Grant this year. With this latest award, Children’s has received more than $2.6 million in grants from Hyundai Hope on Wheels, the non profit arm of Hyundai Motor America,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2018 Category: Pharmaceuticals Authors: Veneta Rizvic Source Type: news

New Data on QoL With Apalutamide in Prostate Cancer New Data on QoL With Apalutamide in Prostate Cancer
Delayed deterioration of quality of life was consistent with longer time to symptomatic progression, according to new data from the SPARTAN trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Monsanto asks judge to throw out $289M award in cancer suit
Agribusiness giant Monsanto is asking a San Francisco judge to throw out a jury's $289 million award to a former school groundskeeper who said the company' Roundup weed killer left him dying of cancer (Source: ABC News: Health)
Source: ABC News: Health - September 19, 2018 Category: Consumer Health News Tags: Health Source Type: news

Paramedics Still Assist Puerto Rican Kidney Patients a Year After Maria
VIEQUES, Puerto Rico (AP) — As weeks turned into months, the seats of the small plane began to empty out. In the beginning, 15 passengers flew from Vieques to the Puerto Rican mainland — refugees from Hurricane Maria. The storm had ruined the only dialysis center on this tiny island, their home; without treatment, the kidney patients would die. But the thrice-weekly trips have taken a toll on these frail patients. Five have died in this past year from causes ranging from heart failure to cancer, but advocates insist that the very flights that keep the patients alive have hastened their deaths. The mortality rat...
Source: JEMS: Journal of Emergency Medical Services News - September 19, 2018 Category: Emergency Medicine Authors: Danica Coto, Associated Press Tags: Patient Care News Source Type: news

Paramedics Still Assist Puerto Rican Kidney Patients a Year After Maria
VIEQUES, Puerto Rico (AP) — As weeks turned into months, the seats of the small plane began to empty out. In the beginning, 15 passengers flew from Vieques to the Puerto Rican mainland — refugees from Hurricane Maria. The storm had ruined the only dialysis center on this tiny island, their home; without treatment, the kidney patients would die. But the thrice-weekly trips have taken a toll on these frail patients. Five have died in this past year from causes ranging from heart failure to cancer, but advocates insist that the very flights that keep the patients alive have hastened their deaths. The mortality rat...
Source: JEMS Patient Care - September 19, 2018 Category: Emergency Medicine Authors: Danica Coto, Associated Press Tags: Patient Care News Source Type: news

CSA Medical touts QoL improvements in RejuvenAir chronic bronchitis study
CSA Medical today released early results from a feasibility study exploring the use of its RejuvenAir Metered Cryospray system in treating patients with chronic bronchitis, touting improvements in quality of life for patients treated with the system. Results from the trial were presented at the 2018 European Respiratory Society Congress in Paris, the Boston-based company said. “We are encouraged by these positive safety and feasibility results and we’re moving forward with plans to initiate a worldwide pivotal study of RejuvenAir in chronic bronchitis in 2019. We look forward to advancing this novel therap...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory CSA Medical Inc. Source Type: news

EPA Plan Will Maintain Carbon Emissions From Power Plants
Inadequate regulation of carbon pollution will likely have current, future consequences for human health (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 19, 2018 Category: Cancer & Oncology Tags: Cardiology, Internal Medicine, Allergy, Oncology, Pediatrics, Pulmonology, Institutional, Source Type: news

Second HPV - Related Primary Cancers Common in Survivors
Persistent HPV infection may be associated with second HPV - related primary cancers (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 19, 2018 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Gynecology, Infections, Internal Medicine, Nursing, Oncology, ENT, Pathology, Urology, Journal, Source Type: news

Patient Health Information Often Shared Electronically
Most commonly observed types of PHI sent are referrals, laboratory results, medication lists (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 19, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Biopharmaceutical company fined for misleading investors
A Colorado-based biopharmaceutical company must pay more than $20 million for misleading investors about the efficacy of a lung cancer drug under development before raising $300 million in a public stock offering (Source: ABC News: Health)
Source: ABC News: Health - September 19, 2018 Category: Consumer Health News Tags: Health Source Type: news

Morning Break: Budget Hike for NIH; Riding the'Canna-Bus'; Junk Food and Cancer
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 19, 2018 Category: Psychiatry Source Type: news

Clovis forks over $20m to settle SEC charges that it misled investors
The SEC said today that Clovis Oncology (NSDQ:CLVS), its CEO and former CFO will pay more than $20 million to settle charges that the company misled investors about its experimental lung cancer drug. The SEC alleged that beginning in July 2015 and over the course of a four-month period, CEO Patrick Mahaffy and his team at Clovis boasted that their investigational lung cancer drug sported a 60% efficacy rate. The company went on to raise $298 million in a public stock offering. Get the full story at our sister site, Drug Delivery Business News. The post Clovis forks over $20m to settle SEC charges that it misled i...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Featured Legal News Oncology Pharmaceuticals Wall Street Beat clovisoncology Source Type: news

5 Facts Every Woman Should Know About Ovarian Cancer
WEDNESDAY, Sept. 19, 2018 -- The early symptoms of ovarian cancer are often confused with less serious issues, making successful treatment less likely, a cancer expert warns. Ovarian cancer is called a " silent killer. " That's because many women are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 19, 2018 Category: General Medicine Source Type: news

MONALEESA-3 Expands Endocrine Tx for Advanced Breast Cancer MONALEESA-3 Expands Endocrine Tx for Advanced Breast Cancer
The MONALEESA-3 trial marks an important step forward for endocrine therapies for advanced breast cancer, argues Lidia Schapira.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news

Enhancing Cancer Immunotherapy with Artificial Intelligence
Physicians may soon use artificial intelligence (AI) and medical images to study tumors without a biopsy. The techniques developed to study tumors in this new way are described in the September 1 issue of The Lancet Oncology. Along with helping physicians learn more about tumors without surgery, the new approach should help identify which cancer patients will respond best to cutting-edge immunotherapy treatments. The AI techniques could be useful for “predicting clinical outcomes of patients treated with immunotherapy when validated by further prospective randomized trials,” the authors wrote. Immunotherapy tre...
Source: Asbestos and Mesothelioma News - September 19, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Could AI Automate Diagnosis ( & Targeted Tx) of Lung Cancer? Could AI Automate Diagnosis ( & Targeted Tx) of Lung Cancer?
Deep-learning neural networks show promise for automating lung cancer classification and for identifying genetic mutations within seconds.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

' Twitter Cheerleaders': A Megaphone for Bad Science'Twitter Cheerleaders': A Megaphone for Bad Science
A new class of physician has emerged in the era of social media: cheerleaders who hype new cancer drugs on Twitter. But what we desperately need are realistic scientific appraisals, argues Vinay Prasad.A new class of physician has emerged in the era of social media: cheerleaders who hype new cancer drugs on Twitter. But what we desperately need are realistic scientific appraisals, argues Vinay PraMedscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news

Four little girls who beat cancer pose for touching photo
If it didn't say 'SURVIVOR' on their t-shirts, you would be hard-pushed to guess that McKinley, Chloe, Ava and Lauren, of Florida, all endured and defeated something few of their peers have faced: cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - September 19, 2018 Category: Consumer Health News Source Type: news

NLR Predicts Survival After Cytoreductive Nephrectomy+Thrombectomy
Preoperative neutrophil-lymphocyte ratio (NLR) may predict survival following cytoreductive nephrectomy plus thrombectomy for renal cell carcinoma (RCC), a new study suggest.09/19/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - September 19, 2018 Category: Urology & Nephrology Source Type: news

Medical News Today: Do low vitamin D levels increase breast cancer risk?
New research finds more evidence that low levels of vitamin D are linked to a heightened risk of breast cancer. Obesity is also a factor, authors confirm. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 19, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Kidney Cancer: Risk Factors and Prevention
This article discusses the risk factors that can cause kidney cancer and what people can do to lower their chances of developing the condition.09/19/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - September 19, 2018 Category: Urology & Nephrology Source Type: news

Boulder biopharma firm, CEO and former exec settle with SEC for $20.8 million
The SEC had alleged the firm misled its investors about the effectiveness of the company ’s cancer drug. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2018 Category: Biotechnology Authors: Monica Vendituoli Source Type: news

Boulder biopharma firm, CEO and former exec settle with SEC for $20.8 million
The SEC had alleged the firm misled its investors about the effectiveness of the company ’s cancer drug. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 19, 2018 Category: Health Management Authors: Monica Vendituoli Source Type: news

E-Cigarette Warnings Coming To High School Bathrooms Nationwide
By Sandee LaMotte, CNN (CNN) — The US Food and Drug Administration will stage a massive education campaign aimed at the nearly 10.7 million teens at risk for e-cigarette use and potential addiction, the agency said Tuesday. For the first time, the agency will take the message that vaping is dangerous into high school bathrooms and social media feeds of those at-risk youth to stop what the FDA calls an epidemic of e-cigarette use by minors. The trend was flagged in a 2016 report from the US surgeon general, which cited a 900% increase in e-cigarette use by high school students between 2011 to 2015. More than 2 million...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 19, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News e-cigarettes FDA vaping Source Type: news

Galera Therapeutics raises $150 million in largest-ever Series C raise by a St. Louis bioscience company
Clinical-stage drug discovery company Galera Therapeutics has raised $150 million in a Series C financing and royalty purchase agreement. According to a release, it is the largest ever Series C raise by a St. Louis bioscience company. Led by Clarus, proceeds from the raise will be used for the clinical development of the drug GC4419, which has shown to reduce the incidence and duration of severe oral mucositis, a side effect of radiation treatment in head and neck cancer patients that causes painful… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2018 Category: Biotechnology Authors: Vince Brennan Source Type: news

Galera Therapeutics raises $150 million in largest-ever Series C raise by a St. Louis bioscience company
Clinical-stage drug discovery company Galera Therapeutics has raised $150 million in a Series C financing and royalty purchase agreement. According to a release, it is the largest ever Series C raise by a St. Louis bioscience company. Led by Clarus, proceeds from the raise will be used for the clinical development of the drug GC4419, which has shown to reduce the incidence and duration of severe oral mucositis, a side effect of radiation treatment in head and neck cancer patients that causes painful… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 19, 2018 Category: Health Management Authors: Vince Brennan Source Type: news

Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer
(Source: Johnson and Johnson)
Source: Johnson and Johnson - September 19, 2018 Category: Pharmaceuticals Source Type: news

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)
Second Orphan Drug Designation for OBI-3424, a novel first-in-class targeted therapy for solid and liquid tumors that express aldo-keto reductase 1c3 (AKR1C3) enzyme TAIPEI, Taiwan, Sept. 19, 2018 -- (Healthcare Sales & Marketing Network) -- OBI Pharma... Biopharmaceuticals, Oncology, FDA OBI Pharma, Acute Lymphoblastic Leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2018 Category: Pharmaceuticals Source Type: news

Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy
Several companies working in the burgeoning field of immuno-oncology have staged IPOs this year, and at least two more are on the way. But will enthusiastic investors be patient enough to see a payoff? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 19, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news

Second HPV-Related Primary Cancers Common in Survivors
WEDNESDAY, Sept. 19, 2018 -- The risk of human papillomavirus-associated second primary cancers (HPV-SPCs) among survivors of HPV-associated cancers is significant, according to a study published online Sept. 7 in JAMA Network Open. Ryan Suk, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 19, 2018 Category: Pharmaceuticals Source Type: news

Vitamin D deficiency linked to increased breast cancer risk
Research, published inMenopause, suggests that women with vitamin D deficiency have a higher risk of developing breast cancer.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 19, 2018 Category: Endocrinology Source Type: news

New Baptist M.D. Anderson Cancer Center is game-changer for Southeast
It took four years and $184 million to build Baptist Health ’s M.D. Anderson Cancer Center. But now that the facility is complete, Baptist is poised to make a name for itself as a leader in cancer treatment in the Southeast. The 330,000-square-foot building serves as a one-stop destination for everything a cancer patient needs – pathologists, radiologi sts, a pharmacy that has every cancer drug on the market, clinical trials of the latest treatments and a team of experts collaborating on the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 19, 2018 Category: Pharmaceuticals Authors: Allison Colburn Source Type: news

Four people get cancer from donated organs
Four European patients developed breast cancer after receiving organs from the same donor, a case report explains. (Source: CNN.com - Health)
Source: CNN.com - Health - September 19, 2018 Category: Consumer Health News Source Type: news